Show simple item record

dc.contributor.authorHolly, Elizabeth N.
dc.contributor.authorMiczek, Klaus A.
dc.date.accessioned2016-08-26T17:52:36Z
dc.date.available2017-03-01T16:14:48Z
dc.date.issued2015-12
dc.date.submitted2015-08
dc.identifier.issn0033-3158
dc.identifier.issn1432-2072
dc.identifier.urihttp://hdl.handle.net/1721.1/104043
dc.description.abstractAversive events rapidly and potently excite certain dopamine neurons in the ventral tegmental area (VTA), promoting phasic increases in the medial prefrontal cortex and nucleus accumbens. This is in apparent contradiction to a wealth of literature demonstrating that most VTA dopamine neurons are strongly activated by reward and reward-predictive cues while inhibited by aversive stimuli. How can these divergent processes both be mediated by VTA dopamine neurons? The answer may lie within the functional and anatomical heterogeneity of the VTA. We focus on VTA heterogeneity in anatomy, neurochemistry, electrophysiology, and afferent/efferent connectivity. Second, recent evidence for a critical role of VTA dopamine neurons in response to both acute and repeated stress will be discussed. Understanding which dopamine neurons are activated by stress, the neural mechanisms driving the activation, and where these neurons project will provide valuable insight into how stress can promote psychiatric disorders associated with the dopamine system, such as addiction and depression.en_US
dc.publisherSpringer Berlin Heidelbergen_US
dc.relation.isversionofhttp://dx.doi.org/10.1007/s00213-015-4151-3en_US
dc.rightsArticle is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.en_US
dc.sourceSpringer Berlin Heidelbergen_US
dc.titleVentral tegmental area dopamine revisited: effects of acute and repeated stressen_US
dc.typeArticleen_US
dc.identifier.citationHolly, Elizabeth N., and Klaus A. Miczek. “Ventral Tegmental Area Dopamine Revisited: Effects of Acute and Repeated Stress.” Psychopharmacology 233, no. 2 (December 17, 2015): 163-186.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Brain and Cognitive Sciencesen_US
dc.contributor.departmentMcGovern Institute for Brain Research at MITen_US
dc.contributor.mitauthorHolly, Elizabeth N.en_US
dc.relation.journalPsychopharmacologyen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2016-05-23T12:09:11Z
dc.language.rfc3066en
dc.rights.holderSpringer-Verlag Berlin Heidelberg
dspace.embargo.termsNen
mit.licensePUBLISHER_POLICYen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record